Cargando…

Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency

Aromatic L-amino acid decarboxylase deficiency (AADCD) is a rare, autosomal recessive neurometabolic disorder that leads to a severe combined deficiency of serotonin, dopamine, norepinephrine and epinephrine. Onset is early in life, and key clinical symptoms are hypotonia, movement disorders (oculog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wassenberg, Tessa, Molero-Luis, Marta, Jeltsch, Kathrin, Hoffmann, Georg F., Assmann, Birgit, Blau, Nenad, Garcia-Cazorla, Angeles, Artuch, Rafael, Pons, Roser, Pearson, Toni S., Leuzzi, Vincenco, Mastrangelo, Mario, Pearl, Phillip L., Lee, Wang Tso, Kurian, Manju A., Heales, Simon, Flint, Lisa, Verbeek, Marcel, Willemsen, Michèl, Opladen, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241937/ https://www.ncbi.nlm.nih.gov/pubmed/28100251 http://dx.doi.org/10.1186/s13023-016-0522-z

Ejemplares similares

AADC deficiency from infancy to adulthood: Symptoms and developmental outcome in an international cohort of 63 patients
por: Pearson, Toni S., et al.
Publicado: (2020)

Blood, urine and cerebrospinal fluid analysis in TH and AADC deficiency and the effect of treatment
por: Wassenberg, Tessa, et al.
Publicado: (2021)

Correction to: Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies
por: Opladen, Thomas, et al.
Publicado: (2020)

Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH(4)) deficiencies
por: Opladen, Thomas, et al.
Publicado: (2020)

Aromatic L-amino Acid Decarboxylase (AADC) deficiency: results from an Italian modified Delphi consensus
por: Fusco, Carlo, et al.
Publicado: (2021)

Aromatic L-Amino Acid Decarboxylase (AADC) Is Crucial for Brain Development and Motor Functions
por: Shih, De-Fen, et al.
Publicado: (2013)

Gene therapy in the putamen for curing AADC deficiency and Parkinson's disease
por: Hwu, Paul Wuh‐Liang, et al.
Publicado: (2021)

The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on primary and secondary neurotransmitter disorders
por: Opladen, Thomas, et al.
Publicado: (2016)

Clinical Features in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Systematic Review
por: Rizzi, Susanna, et al.
Publicado: (2022)

A Discrete Choice Experiment to Derive Health Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
por: Smith, Adam B, et al.
Publicado: (2021)

Compound Heterozygosis in AADC Deficiency and Its Complex Phenotype in Terms of AADC Protein Population
por: Bisello, Giovanni, et al.
Publicado: (2022)

A Discrete Choice Experiment to Derive Health Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency in France
por: Smith, Adam B, et al.
Publicado: (2022)

Eliciting health state utilities for Aromatic L-amino Acid Decarboxylase (AADC) deficiency: a UK vignette study
por: Smith, Adam B., et al.
Publicado: (2021)

Symptoms and impacts of aromatic l-amino acid decarboxylase (AADC) deficiency among individuals with different levels of motor function
por: Williams, Kate, et al.
Publicado: (2022)

Eliciting Health State Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Vignette Study in France
por: Smith, Adam B, et al.
Publicado: (2021)

Tyrosine Hydroxylase (TH)- and Aromatic-L-Amino Acid Decarboxylase (AADC)-Immunoreactive Neurons of the Common Marmoset (Callithrix jacchus) Brain: An Immunohistochemical Analysis
por: Karasawa, Nobuyuki, et al.
Publicado: (2007)

Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons
por: Pearson, Toni S., et al.
Publicado: (2021)

Long-Term Outcomes of Eladocagene Exuparvovec Compared with Standard of Care in Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency: A Modelling Study
por: Simons, Claire L., et al.
Publicado: (2023)

Insights into the expanding phenotypic spectrum of inherited disorders of biogenic amines
por: Kuseyri Hübschmann, Oya, et al.
Publicado: (2021)

Biochemical diagnosis of aromatic-L-amino acid decarboxylase deficiency (AADCD) by assay of AADC activity in plasma using liquid chromatography/tandem mass spectrometry
por: Civallero, Gabriel, et al.
Publicado: (2022)

Depletion of AADC activity in caudate nucleus and putamen of Parkinson’s disease patients; implications for ongoing AAV2-AADC gene therapy trial
por: Ciesielska, Agnieszka, et al.
Publicado: (2017)

Role of Endothelial AADC in Cardiac Synthesis of Serotonin and Nitrates Accumulation
por: Rouzaud-Laborde, Charlotte, et al.
Publicado: (2012)

Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency
por: Tai, Chun-Hwei, et al.
Publicado: (2022)

Aromatic l-amino acid decarboxylase deficiency: a patient-derived neuronal model for precision therapies
por: Rossignoli, Giada, et al.
Publicado: (2021)

Urinary sulphatoxymelatonin as a biomarker of serotonin status in biogenic amine-deficient patients
por: Batllori, Marta, et al.
Publicado: (2017)

Case report: First case report of an Emirati child with a novel gene variant causing aromatic L-amino acid decarboxylase deficiency
por: Babiker, Mohamed O. E., et al.
Publicado: (2022)

Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
por: van Rumund, Anouke, et al.
Publicado: (2021)

Safety and tolerability of MRI-guided infusion of AAV2-hAADC into the mid-brain of nonhuman primate
por: Sebastian, Waldy San, et al.
Publicado: (2014)

Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease
por: Christine, Chadwick W., et al.
Publicado: (2019)

Improvement of the Rett Syndrome Phenotype in a Mecp2 Mouse Model Upon Treatment with Levodopa and a Dopa-Decarboxylase Inhibitor
por: Szczesna, Karolina, et al.
Publicado: (2014)

Cerebrospinal Fluid Neopterin Analysis in Neuropediatric Patients: Establishment of a New Cut Off-Value for the Identification of Inflammatory-Immune Mediated Processes
por: Molero-Luis, Marta, et al.
Publicado: (2013)

Carbidopa-Based Modulation of the Functional Effect of the AAV2-hAADC Gene Therapy in 6-OHDA Lesioned Rats
por: Ciesielska, Agnieszka, et al.
Publicado: (2015)

Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial
por: Christine, Chadwick W., et al.
Publicado: (2022)

U-IMD: the first Unified European registry for inherited metabolic diseases
por: Opladen, Thomas, et al.
Publicado: (2021)

Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice
por: Pai, Yun Jin, et al.
Publicado: (2015)

Improvement of the Process Stability of Arylmalonate Decarboxylase by Immobilization for Biocatalytic Profen Synthesis
por: Aßmann, Miriam, et al.
Publicado: (2017)

Phenotypic Correlates of Structural and Functional Protein Impairments Resultant from ALDH5A1 Variants
por: Latzer, Itay Tokatly, et al.
Publicado: (2023)

Deriving Vignettes for the Rare Disease AADC Deficiency Using Parent, Caregiver and Clinician Interviews to Evaluate the Impact on Health-Related Quality of Life
por: Hanbury, Andria, et al.
Publicado: (2021)

Aromatic L-Amino acid decarboxylase deficiency: A new case from Turkey with a novel mutation
por: Gücüyener, Kıvılcım, et al.
Publicado: (2014)

The novel P330L pathogenic variant of aromatic amino acid decarboxylase maps on the catalytic flexible loop underlying its crucial role
por: Bisello, Giovanni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aeeurqbr3mor2chsbkhpd8tvcv